Walgreens Reports $2.9B Q2 Loss Amid Strategy Restructuring and Store Closures

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has faced a challenging period in its recent second-quarter fiscal 2025 results. The company reported a net loss attributable to Walgreens Boots Alliance of $2.9 billion for the quarter, a significant decrease from the previous year. This loss reflects a series of operational difficulties and market pressures, resulting in a strategy reassessment and restructuring initiatives.

Positive Aspects:

• Sales increased to $38.6 billion in Q2 2025, up from $37.1 billion in Q2 2024.
• Improvement in operational efficiency, with an adjusted operating income of $785 million, albeit lower than the prior year.
• Net loss per share improved to $(3.30) from $(6.85) in the same quarter last year, highlighting a reduction in losses.
• Other income rose substantially to $1.5 billion compared to $195 million the previous year, driven by gains from equity investments.

Negative Aspects:

• Impairment charges totaled $5.3 billion, significantly impacting net income, primarily due to goodwill impairment.
• Operating loss was reported at $5.6 billion, compared to a loss of $13.2 billion the previous year, raising concerns about ongoing operational effectiveness.
• Selling, general, and administrative expenses increased sharply to $8.9 billion, driven by higher legal settlements and costs related to the Footprint Optimization Program.
• Cash and cash equivalents decreased sharply to $702 million from $1.3 billion, indicating liquidity constraints.
• The company has suspended its cash dividend to stockholders to strengthen the balance sheet amid financial restructuring.

Key Statistics and Metrics:

• Q2 2025 Net Loss: $2.9 billion (+51.7% year-over-year)
• Net Loss Per Share: $(3.30) (compared to $(6.85) in Q2 2024)
• Sales: $38.6 billion (up 4.1% from Q2 2024)
• Adjusted Operating Income: $785 million (down from $900 million in Q2 2024)
• Cash and Cash Equivalents: $702 million
• Total Assets: $70.2 billion (down from $81.0 billion from last year)
• Long-term Debt: $8.0 billion (part of total liabilities at $63.0 billion)

Walgreens is undergoing significant changes through its Footprint Optimization Program, stating plans to close 900 to 1,000 stores by 2027 to realign with market conditions. The strategic review aims to cut costs and refocus core operations, especially as competition and legal issues surrounding opioid prescriptions and litigation weigh on the company.

As the company moves forward, ongoing management of liquidity and operational restructuring will be pivotal in determining its medium-term recovery trajectory and shareholder confidence.